Daniel Beachler
As the Senior Director of Safety and Epidemiology team at Carelon Research, Dr. Beachler oversees the execution of pharmacoepidemiology, risk management, and medical product safety studies for a portfolio of industry, academic, and government clients. Dr. Beachler has experience conducting validation studies and utilizing predictive modeling and machine learning methods to develop claims-based algorithms to improve cohort and outcome classification. He has scientific oversight of drug safety studies including post authorization safety studies (PASS), Risk Evaluation and Mitigation Strategy (REMS), post-market requirement (PMR) studies. Prior to joining HealthCore, Dr. Beachler was a Cancer Prevention Fellow at the National Cancer Institute, Division of Cancer Epidemiology and Genetics. Dr. Beachler has published dozens of manuscripts in the peer-reviewed medical literature. He has presented his work at scientific meetings and to regulatory authorities worldwide.
